Budesonide and Prograf drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Budesonide (budesonide) and Prograf (tacrolimus). Common drug interactions include cellulitis among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Budesonide and Prograf. It is created by eHealthMe based on reports of 87 people who take the same drugs from the FDA, and is updated regularly.

What is Budesonide?

Budesonide has active ingredients of budesonide. It is often used in asthma. eHealthMe is studying from 42,933 Budesonide users. Check the latest studies of Budesonide.

What is Prograf?

Prograf has active ingredients of tacrolimus. It is often used in kidney transplant. eHealthMe is studying from 42,230 Prograf users. Check the latest studies of Prograf.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 27, 2026

87 people who take Budesonide and Prograf together, and have interactions are studied.

Budesonide and Prograf drug interactions.

What are the common drug interactions of Budesonide and Prograf, by gender? *:

female:

  1. Cellulitis (infection under the skin)
  2. Colitis (inflammation of colon)
  3. Conjunctival disorder (conjunctival disease)
  4. Conjunctival oedema (conjunctival swelling)
  5. Contusion (a type of hematoma of tissue in which capillaries)
  6. Cushingoid (obesity and weakening of the muscles)
  7. Cytomegalovirus infection
  8. Cytomegalovirus viraemia (cytomegalo virus in blood stream)
  9. Defaecation urgency (a sudden compelling urge to defecate)
  10. Dental caries

male:

  1. Fatigue (feeling of tiredness)
  2. Diarrhoea
  3. Weight increased
  4. Abdominal pain
  5. Blood pressure decreased
  6. Brain oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain)
  7. Bruxism (habitual grinding of the teeth, typically during sleep)
  8. Depressed level of consciousness
  9. Disseminated intravascular coagulation (systemic activation of blood coagulation)
  10. Dyskinesia (abnormality or impairment of voluntary movement)

What are the common drug interactions of Budesonide and Prograf, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Intra-abdominal haemorrhage (intra-abdominal bleeding)

10-19:

  1. Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
  2. Bacteroides bacteraemia
  3. Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
  4. Thrombotic microangiopathy (a pathology that results in thrombosis in capillaries and arterioles, due to an endothelial injury)
  5. Abdominal pain
  6. Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
  7. Bacteraemia (presence of bacteria in the blood)
  8. Bk virus infection
  9. Cytomegalovirus hepatitis (virus infection of liver)
  10. Cytomegalovirus infection

20-29:

  1. Blood pressure decreased
  2. Brain oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain)
  3. Bruxism (habitual grinding of the teeth, typically during sleep)
  4. Depressed level of consciousness
  5. Disseminated intravascular coagulation (systemic activation of blood coagulation)
  6. Dyskinesia (abnormality or impairment of voluntary movement)
  7. Ecchymosis (a discoloration of the skin resulting from bleeding underneath)
  8. Fatigue (feeling of tiredness)
  9. Kidney transplant rejection
  10. Mydriasis (a dilation of the pupil)

30-39:

  1. Thrombotic microangiopathy (a pathology that results in thrombosis in capillaries and arterioles, due to an endothelial injury)
  2. Abdominal pain
  3. Constipation
  4. Hepatic enzyme increased
  5. Death
  6. Diarrhoea
  7. Hypersensitivity
  8. Lethargy (tiredness)
  9. Oesophageal candidiasis (fungal infection of oesophagus)
  10. Overdose

40-49:

  1. Activated partial thromboplastin time prolonged
  2. Cardiac arrest
  3. Catatonia (unresponsive to external stimuli)
  4. Catheter bacteraemia (bacterial infection in blood due to catheter)
  5. Constipation
  6. Depression
  7. Haematocrit decreased
  8. Haemoglobin decreased
  9. Headache (pain in head)
  10. International normalised ratio increased

50-59:

  1. Hyperglycaemia (high blood sugar)
  2. Hyperkalaemia (damage to or disease of the kidney)
  3. Hypoaldosteronism (decreased levels of the hormone aldosterone)
  4. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
  5. Immunosuppressant drug level increased
  6. Injection site bruising
  7. Insomnia (sleeplessness)
  8. Intestinal polyp (small growths in the bowel with the potential for further growth)
  9. Lymphadenopathy (disease or enlargement of lymph nodes)
  10. Lymphopenia (an abnormally low level of lymphocytes in the blood)

60+:

  1. Renal failure (kidney dysfunction)
  2. Cough
  3. Haemorrhage intracranial (bleeding within the skull)
  4. Abdominal discomfort
  5. Abdominal pain
  6. Acute graft versus host disease in intestine (acute complication in intestine following an allogeneic tissue/blood transplant)
  7. Ascites (accumulation of fluid in the abdominal cavity)
  8. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  9. Basophil percentage decreased
  10. Blood alkaline phosphatase increased

What are the existing conditions these people have? *

  1. Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 12 people, 13.79%
  2. Cystic Fibrosis (disease of the secretary glands): 9 people, 10.34%
  3. Diarrhea: 8 people, 9.20%
  4. Nausea (feeling of having an urge to vomit): 7 people, 8.05%
  5. High Blood Pressure: 7 people, 8.05%
  6. Diabetes: 7 people, 8.05%
  7. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 5 people, 5.75%

* Approximation only. Some reports may have incomplete information.

Do you take Budesonide and Prograf?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Budesonide and Prograf:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Budesonide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Prograf:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Budesonide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Prograf and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on budesonide and tacrolimus (the active ingredients of Budesonide and Prograf, respectively), and Budesonide and Prograf (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: